Radcliffe & CardioNerds @AHA22: The RESPECT EPA Trial

Published: 15 Nov 2022

  • Views:

    Views Icon 498
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

AHA 22 - CardioNerds Fellow, Dr Saahil A Jumkhawala (Rutgers New Jersey Medical School, US) joins us in this collaboration between the @CardioNerds and Radcliffe Cardiology to interview Prof Hiroyuki Daida (Juntendo Graduate School of Medicine, JP) investigator of the RESPECT EPA trial.

This randomized phase 4 trial looked at Japanese participants to assess whether long-term use of icosapent ethyl 1800 mg daily in addition to statin therapy would be more effective in preventing cardiovascular events in patients with hypercholesterolemia compared to station therapy alone. 

Access our full AHA 22 Scientific Coverage here.  

Recorded remotely from Tokyo & New Jersey, 2022.

Editor: Mirjam Boros, Jordan Rance
Video Specialist: Oliver Miles